Carvedilol
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Carvedilol and local guidelines before prescribing.
Mechanism
Non-selective beta blocker with alpha-1 blocking activity.
Uses
Heart failure with reduced EF, hypertension, post-MI.
Dosing
- Carvedilol | 3.125 mg twice daily initially; target commonly 25 mg twice daily.
Cardiology: Heart Failure › 2.33 💊 Common Drugs and Adult Doses - Carvedilol | HFrEF: 3.125 mg twice daily, titrated to 25 mg twice daily (50 mg twice daily if >85 kg).
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses - Carvedilol (a non-selective beta-blocker) - 6.25 mg once daily, increasing to 12.5 mg daily if tolerated (keep systolic BP over 90 mmHg).
Gastroenterology: Cirrhosis and Transplantation - Carvedilol 6.25 mg daily, up to 12.5 mg daily | Primary and secondary variceal prophylaxis; prevents decompensation in CSPH; reduce or stop if systolic BP under 90, AKI or refractory ascites.
Gastroenterology: Cirrhosis and Transplantation
Side effects
Dizziness, postural hypotension, fatigue, bradycardia, fluid retention initially.
Interactions
Amiodarone and rate-limiting calcium channel blockers risk bradycardia and block; insulin hypoglycaemia masking.
Contraindications and cautions
Asthma, heart block, severe hepatic impairment, decompensated heart failure
Monitoring
Pulse, BP, postural symptoms
Pregnancy and breastfeeding
Avoid unless essential
Renal and hepatic impairment
Contraindicated in severe liver impairment
Overdose and reversal
Atropine, glucagon, supportive
Special advice
Introduce when euvolaemic and titrate slowly; avoid in asthma and decompensated heart failure.
More from the textbook: uses, cautions and other points
- Non-selective - propranolol (also used for thyrotoxicosis, migraine, varices, anxiety), sotalol (also class III), carvedilol (also alpha-blocking), labetalol (pregnancy hypertension).
Cardiology: Anatomy Physiology and Pharmacology - Uses - angina, after MI, HFrEF (bisoprolol, carvedilol, nebivolol, metoprolol succinate -"start low, go slow"), AF rate control, SVT, hypertension (not first-line alone), thyrotoxicosis.
Cardiology: Anatomy Physiology and Pharmacology - Evidence-based agents : Bisoprolol. Carvedilol. Metoprolol succinate modified-release. Nebivolol in selected patients.
Cardiology: Heart Failure › 2.19 💊 Beta Blockers - Non-selective beta-blockers - carvedilol (preferred in BSG guidance) or propranolol - lower portal pressure; for primary prevention of variceal bleeding (medium or large varices) and, with banding, secondary prevention. Hold or reduce if systolic BP is under 90 , AKI, sepsis or SBP, and use with care in refractory ascites.
Gastroenterology: Anatomy Physiology Pharmacology - Carvedilol / propranolol | Lower portal pressure; prevent variceal bleeding; hold if hypotensive or AKI.
Gastroenterology: Anatomy Physiology Pharmacology - Afterwards: Non-selective beta-blocker (carvedilol or propranolol) plus a band ligation programme to prevent rebleeding.
Gastroenterology: Gastroenterology Emergencies (Complete)
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Heart Failure (2 mentions)
- Cardiology: Cardiomyopathies (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Cirrhosis and Transplantation (5 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Integrated cardiology chapter (3 mentions)